Switch to
More onapp

Aarti Drugs Ltd

AARTIDRUGS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,779 cr, stock is ranked 595
Low RiskStock is 1.87x as volatile as Nifty
402.206.00 (-1.47%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,779 cr, stock is ranked 595
Low RiskStock is 1.87x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
18.44
PB RatioPB Ratio
3.65
Dividend YieldDiv. Yield
0.24%
Sector PESector PE
33.90
Sector PBSector PB
4.15
Sector Div YldSctr Div Yld
0.93%

Forecast & RatingsDetailed Forecast 

33%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Aarti Drugs Limited is a pharmaceutical company offering active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins.

Investor PresentationView older 

Jan 27, 2023

PDF
View Older Presentations

Financial TrendFinancial statements 

20192020202120221.571.812.162.500.090.140.280.21
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnJan 30, 2023

Aarti Drugs Limited has informed the Exchange about Link of Recording | Download

Aarti Drugs Limited has informed the Exchange about Link of Recording | Download

Press Release 
Announced OnJan 27, 2023

Aarti Drugs Limited has informed the Exchange regarding a press release dated January 27, 2023, titled "Aarti Drugs Limited Reports its Q3 & 9MFY23 FinancialResults". | Download

Aarti Drugs Limited has informed the Exchange regarding a press release dated January 27, 2023, titled "Aarti Drugs Limited Reports its Q3 & 9MFY23 FinancialResults". | Download

Cash Dividend 
Ex. DateFeb 9, 2022

Interim • Div/Share: ₹ 1

See all events